Rethinking the Prevalence of Exercise-induced Bronchoconstriction in Patients with Asthma
Overview
Overview
Journal
Ann Allergy Asthma Immunol
Specialties
Allergy & Immunology
Pulmonary Medicine
Pulmonary Medicine
Date
2013 Nov 26
PMID
24267370
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
VILLARAN C, ONeill S, Helbling A, van Noord J, Lee T, Chuchalin A
. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol. 1999; 104(3 Pt 1):547-53.
DOI: 10.1016/s0091-6749(99)70322-2.
View
2.
Pearlman D, Qaqundah P, Matz J, Yancey S, Stempel D, Ortega H
. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pediatr Pulmonol. 2009; 44(5):429-35.
DOI: 10.1002/ppul.20962.
View
3.
Crapo R, Casaburi R, Coates A, Enright P, Hankinson J, Irvin C
. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):309-29.
DOI: 10.1164/ajrccm.161.1.ats11-99.
View
4.
Edelman J, Turpin J, Bronsky E, Grossman J, Kemp J, Ghannam A
. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med. 2000; 132(2):97-104.
DOI: 10.7326/0003-4819-132-2-200001180-00002.
View
5.
Weiler J, Anderson S, Randolph C, Bonini S, Craig T, Pearlman D
. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol. 2010; 105(6 Suppl):S1-47.
DOI: 10.1016/j.anai.2010.09.021.
View